4/19, 10:42 AM (Source: TeleTrader)
more TeleTrader news

China to produce 100M more Russian vaccines per year

The Russian Direct Investment Fund announced on Monday it has reached an agreement with Chinese Hualan Biological Bacterin Inc. on the production of 100 million Sputnik V vaccine doses per year.

"The partnership agreement with Hualan Biological Bacterin, one of the leading vaccine manufacturers in China, will significantly expand production capacity for the production of Sputnik V. China is one of the main partners in the production of the Russian vaccine, which is already used in all regions of the world to protect the health of people and has proven its high efficiency and safety," the fund's head Kirill Dmitriev noted.

Russia has so far finalized contracts with two Chinese companies on the Sputnik V production, TopRidge Pharma and Shenzhen Yuanxing Gene-tech Co., which should provide in total 160 million COVID-19 vaccines per year.

Breaking the News / ND